ClinConnect ClinConnect Logo
Search / Trial NCT06459115

Adherence to Medication in Patients With Acute Decompensated Heart Failure

Launched by UNIVERSITÄT DES SAARLANDES · Jun 10, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

Acute Decompensated Heart Failure Adherence Emergency Department

ClinConnect Summary

This clinical trial is studying how well patients with acute heart failure are sticking to their prescribed heart failure medications. Heart failure can worsen for many reasons, and one of them may be that patients are not taking their medications as directed. Researchers want to see how often patients are adhering to their medications using a precise testing method at the emergency department. They will also use questionnaires to understand what might affect a patient's ability to take their medications regularly.

To be eligible for this study, participants must be at least 18 years old and have a known history of chronic heart failure. They should require intravenous diuretics, which are medications that help remove excess fluid, and they must have been stable on their heart failure medications for at least two weeks. Additionally, participants need to show at least one sign of fluid overload, like swelling or difficulty breathing, and have elevated levels of a specific protein in their blood. If you join this trial, you can expect to provide some information about your health and medications, while also contributing to important research that could help improve care for others with heart failure.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • age ≥18 years of age
  • known chronic heart failure irrespective of ejection fraction (heart failure with reduced, mildly reduced, or preserved ejection fraction)
  • requirement of intravenous diuretics (outpatient or stationary treatment)
  • stable heart failure medication \>2 weeks
  • ≥1 sign of volume overload (peripheral edema, jugular venous distension, pulmonary rales, ascites, or demonstration of pulmonary venous congestion on chest X-ray)
  • elevated natriuretic peptides (N-terminal pro brain natriuretic peptide= nt-pro-BNP ≥125 pg/ml)
  • Exclusion Criteria:
  • - Not able to give written informed consent

About Universität Des Saarlandes

The Universität des Saarlandes is a distinguished academic institution located in Germany, recognized for its commitment to advancing research and education in the medical and health sciences. As a clinical trial sponsor, the university leverages its robust interdisciplinary expertise and state-of-the-art facilities to facilitate innovative research initiatives aimed at addressing critical health challenges. The institution fosters collaboration among researchers, healthcare professionals, and industry partners, ensuring rigorous adherence to ethical standards and regulatory compliance throughout the clinical trial process. Through its dedication to scientific excellence and patient-centered research, Universität des Saarlandes plays a vital role in contributing to the development of novel therapeutic interventions and improving healthcare outcomes.

Locations

Homburg, , Germany

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported